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TERMINOLOGY 
 
Term Definition 
94/46/EC Data protection directive released by European Union. 
AWS Amazon web services, cloud computing service. 
CIO Chief information officer. 
Cloud 
computing 
Use of computing resources as a service across the 
network. 
Computer 
System 
A group of hardware components and associated software 
designed and assembled to perform a specific function or 
group of functions. 
CSA Cloud security alliance. 
EMEA European medicines agency. 
ENISA European union agency for network and information 
security. 
ERP Enterprise resource planning system. 
EU European union. 
EudraLex 
Volume 4 
Annex 11 
European Commission has published a set of guidance for 
manufacturing and distributing medicinal products for 
pharmaceutical industry in the European Union. Annex 11 
applies to computerized systems. 
FDA US food and drug administration. 
FMEA Failure mode effect analysis, systematic analysis tool for 
failure analysis. 
GAMP Good automated manufacturing practice, published by 
ISPE. 
GMP Good manufacturing practice. 
GMP 
significant 
application 
Software application which have direct access to GMP 
data. 
GMPIA GMP impact assessment. 
GxP General term where x represents for example 
manufacturing (“GMP”) or laboratory (“GLP”). 
5 
 
Term Definition 
HIPAA The health insurance portability and accountability act 
(US). 
IaaS Infrastructure as a Service, cloud deployment mode. 
IEEE Institute of electrical and electronics engineers. 
ISACA Global association to promote knowledge and practices. In 
the past known as the Information systems audit and 
control association. 
ISPE International society for pharmaceutical engineering. 
ITU International telecommunication union. 
NIST National institute of standards and testing. 
PaaS Platform as a service, cloud deployment mode. 
QRM Quality risk management. 
Qualification Process of assurance which ensures that predefined 
acceptance criteria can be achieved. 
RPN Risk priority number. 
SaaS Software as a service, cloud deployment mode. 
SAS 70 Auditing standard. 
SSAE-16 Auditing standard. 
SD  System description. A written description of a system, 
including diagrams as appropriate. 
URS  User Requirements Specification. A URS defines, clearly 
and precisely what the user wants the system do. 
US-EU Safe 
Harbor 
Framework for US based companies' compliance for 
95/46/EC directive. 
Validation To establish documented evidence that the system does 
what it was intended to do. 
VA (Vendor 
Assessment) 
Documented evidence that verify that the vendor have a 
high level of confidence and meet with technical, 
commercial, and regulatory requirements. 
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1 INTRODUCTION 
 
Cloud computing and hosted IT services are nowadays becoming more and 
more popular (Bittman 2012). Cloud computing solutions have evolved over 
the time offering better set of tools for all-sized companies and organizations. 
These tools usually contain for example communications management, data 
storage and hosted applications.  
 
Cloud computing has become an essential way of work not just for large 
companies and IT professionals but for regular home computer users. It is 
seldom recognized that popular email services, social networking sites and 
web stores for tabloid and smartphone applications all have in common wide 
utilization of cloud computing services for their infrastructure. Because of this 
lack of understanding cloud computing privacy issues have not been paid 
attention as much as for example for online banking. Small and bigger 
companies have also been neglecting the cloud computing risks and privacy 
issues brought by more attractive and possibly better service levels than 
traditional IT solutions. 
 
However, recently these issues have been brought to public attention even by 
mainstream newspapers publishing news on risks of cloud computing (Lassila 
2012).  
 
Authorities such as European Union (EU), Institute of Electrical and 
Electronics Engineers (IEEE), International Telecommunication Union (ITU) 
and others have taken actions by providing guidelines and standards for cloud 
computing implementation. Various sectors of business need to follow 
different authorities whilst certain top level legislation and directives should be 
followed by all.  
 
This thesis work consists of technology review, regulation and standard 
review, pharmaceutical sector specific technology introduction, information on 
cloud computing security, interview of an expert and from approach model that 
can be used as a template for case studies. 
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2 BACKGROUND TO THE RESEARCH  
 
The purpose of this thesis is to evaluate implementation of cloud computing 
and hosted IT services from pharmaceutical industry point of view. 
Pharmaceutical industry needs to follow regulatory guidelines and 
recommendations from several authorities such as European Union, 
European Medicines Agency and U.S. Food and Drug Administration 
depending on which market area they are focusing.  
 
Various regulatory authors, organizations and commercial service providers 
may offer their solutions but how to evaluate and identify the ones that applies 
for certain sector?   
 
The objectives of the thesis are  
• Gain enough knowledge of cloud computing and hosted IT services to 
support pharmaceutical companies in selection of the relevant 
service(s) 
• Understand implementation requirements  
• Understand regulatory factors   
• Improve technical knowledge and develop fuller understanding on this 
area of technology.  
 
Project deliverables will be recommendations as to whether the technology 
can be applied and if so the benefits to the business, likely costs and 
regulatory consequences. 
 
Main emphasis of the research consists of literature reviews, expert interviews 
and potentially case studies making the research method triangulation instead 
of using just one method. It is likely that theoretical framework will be created, 
analyzed whether framework has theoretical relevance to research problem 
and formed into theoretical body of knowledge. 
 
 
  
8 
 
3 CLOUD COMPUTING 
 
3.1 History of the term 
 
Even though cloud computing has a connection back to early days of 
computing and using shared mainframe computing resources the term cloud 
computing was first time used in the year 1997:  
The first time the term was used in its current context was in a 1997 
lecture by Ramnath Chellappa where he defined it as a new “computing 
paradigm where the boundaries of computing will be determined by 
economic rationale rather than technical limits alone.” (Sourya 2011.) 
 
 
In the 2000s cloud computing has become widely accepted and used term. 
 
3.2 Definitions  
 
By Wikipedia (Cloud computing 2012) cloud computing has the following 
definition: ”Cloud computing is the use of computing resources (hardware and 
software) that are delivered as a service over a network (typically the 
Internet).“  
  
National Institute of Standards and Testing (NIST) definition of cloud 
computing (Mell 2011, 2-3) consists of three sections: Cloud computing has 
five essential characters, three service models and four deployment models. 
 
3.3 Key characteristics of cloud computing by NIST definition 
 
3.3.1 On-demand self-service 
 
This characteristics means that the customer is in control of provisioning 
process and doesn’t need interaction with service provider in order to obtain 
computing resources. For example customer logs in to a self-service portal, 
selects wanted resources, pays and gets resources automatically. 
 
3.3.2 Broad network access 
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This characteristic describes that access to cloud computing resources should 
be available using standard protocols (such as HTTP protocol) and devices 
using thin or thick platforms. It also promotes the idea of computer programs 
interacting with cloud environment using standard protocols – not just people 
and devices (Carstensen, Golden & Morgenthal 2012, 17-18). 
 
3.3.3 Resource pooling 
 
Resource pooling characteristics describes the transition from dedicated 
resources into resource pooling. Computing resources can be assigned 
dynamically as required within organization(s) in efficient manner. End user 
isn’t necessarily aware of the exact location of computing resource. In real life 
scenarios pooling idea has been utilized for hundreds of years; for instance 
tap water uses common pool of water without each individual having their own 
wells. It becomes responsibility of waterworks to provide enough resources to 
the common pool – in similar way end user of computer resource pool cannot 
be responsible for the usage peaks.  
 
3.3.4 Rapid elasticity 
 
User of cloud computing resources needs to be able to obtain computing 
resources quickly at the same time without the feel of running out of 
resources.   
 
3.3.5 Measured service 
 
This characteristic describes that reporting, monitoring and controlling of 
resource usage should be available both for provider and end user in order to 
provide transparency.  
 
3.4 Service models 
 
There are three service models, IaaS, PaaS and SaaS. All three can be 
provided either via on-premise or off-premise solution.  
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3.4.1 Infrastructure as a Service (IaaS) 
 
IaaS was previously known as hardware as a service or HaaS. In this model 
cloud operator provides computers, physical or virtual machines, network and 
the storage space. It is the responsibility of end user to install operating 
system, middleware and application software on those machines and take 
care of application patching. Amazon Web Services (AWS) is an example of 
IaaS implementation. Pay-per-use model is usually used in this 
implementation. 
 
 
Figure 1 – Three main layers of cloud computing (Ludwig 2011) 
 
3.4.2 Platform as a Service (PaaS) 
 
In PaaS the cloud service operator provides same as in IaaS but in addition 
also manages the operating systems, middleware and system runtime. 
Microsoft Azure is one example of PaaS solutions. 
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3.4.3 Software as a Service (SaaS) 
 
SaaS service model requires the least of administration from the end user. 
Usually the end user just needs to connect to an application running on the 
service provider’s platform. Connections to could services can be established 
by internet browser or by a specific client application. An example of SaaS in 
business environment is Cisco’s Webex web meeting software. An enterprise 
resource planning (ERP) software could also be served as a service.  
 
3.5 Deployment models 
 
3.5.1 Public cloud  
 
In public cloud applications, storage and other resources are available to end 
users through internet – direct connection is not in general an option 
(Wikipedia, 2012). According to Turunen (2011, 13) public cloud is the most 
offered solution at the moment. Public cloud is an off-premises solution. 
 
3.5.2 Private cloud  
 
Private cloud is operated within organization’s own borders – cloud computing 
services are available only to selected number of people. Private clouds can 
be managed either by organizations’ own IT department or by external service 
provider. Bittman (2012) suggests that “2012 will be the year that private cloud 
moves from market hype to many pilot and mainstream deployments”. Private 
cloud can be either an on-premises and/or off-premises solution. One 
example of such platform is Amazon Virtual Private Cloud. 
 
3.5.3 Hybrid cloud 
 
Hybrid cloud is a combination of at least two clouds which can be private or 
public clouds. The idea is to provide for example independency from internet-
connection problems by running certain services in a private cloud. Hybrid 
cloud can be either an on-premises and/or off-premises solution. 
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Figure 2 – Cloud computing types (Cloud computing 2012). 
 
3.5.4 Community cloud  
 
Community cloud offers shared resources only for limited number of 
organizations or individuals. Those communities usually have similar 
requirements and they might work in same projects or research. Community 
cloud can be either an on-premises and/or off-premises solution. As an 
example joint venture of pharmaceutical companies could create community 
cloud which complies with specific regulations. 
  
3.6 Cloud service provider pioneers  
 
One of the very first commercial service providers if not the first was 
Salesforce.com which in the year 1999 provided concept for providing 
applications for enterprise use via a website. Others to follow were Amazon 
Web Services (AWS) in the year 2002 and Google docs in 2006. In 2006 
Amazon’s EC2-network was introduced to public as a service where people 
can run their own applications running on Amazon’s hardware (Sourya 2011).  
 
These three companies were in top 10 cloud computing providers in 2012 
(Top 10 cloud computing providers of 2012 2011). 
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3.7 Summary  
 
In this chapter the technology behind cloud computing was reviewed. Different 
service and deployment models may be cumbersome to understand without 
proper introduction especially when these models can be mixed in various 
combinations. Then again – cloud computing uses ancient old concepts like 
resource pooling which was used by Roman Empire in aqueducts to distribute 
water to the end users.  
 
From validation and regulatory point of view it is important to recognize 
technology behind the commercial products.  
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4 REGULATIONS AND STANDARDS FOR IT 
 
4.1 EudraLex Volume 4 Annex 11 
 
European Commission has published a set of guidance for manufacturing and 
distributing medicinal products for pharmaceutical industry in the European 
Union. The title is “EudraLex - Volume 4 of "The rules governing medicinal 
products in the European Union"”. The basic structure has three parts titled 
"Basic Requirements for Medicinal Products", "Basic Requirements for Active 
Substances used as Starting Materials" and "GMP related documents". Parts 
divide into chapters and document templates.  
  
There are nineteen more specific annexes for Volume 4. Annex 11 (EC 2011) 
describes how computerized systems which are used in conjunction with good 
manufacturing practices (GMP) regulated activities should be treated. This 
applies to all pharmaceuticals companies under GMP regulations. Four main 
principles of the Annex 11 state  
 
The application should be validated; IT infrastructure should be 
qualified. Where a computerised system replaces a manual operation, 
there should be no resultant decrease in product quality, process 
control or quality assurance. There should be no increase in the overall 
risk of the process. (EC 2011) 
 
In more details Annex 11 lists requirements under seventeen main clauses for 
computerized systems. 
 
4.2 EU Data Protection Directive 
 
4.2.1 94/46/EC Data Protection Directive 
 
European Union directive 95/46/EC (also known as Data Protection Directive) 
adopted in the year 1995 regulates how personal data can be processed 
within the European Union. Personal data can include credit card numbers, 
addresses, personal records etc. The term processing is defined by Article 2 b  
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'processing of personal data' ('processing') shall mean any operation or 
set of operations which is performed upon personal data, whether or 
not by automatic means, such as collection, recording, organization, 
storage, adaptation or alteration, retrieval, consultation, use, disclosure 
by transmission, dissemination or otherwise making available, 
alignment or combination, blocking, erasure or destruction (EC 1995) 
 
A point worth noticing from cloud computing point of view is that the directive 
doesn’t separate manual or automatic data processing; it applies to both data 
handling methods.  
 
4.2.2 General Data Protection Regulation 
 
A new legal framework proposal to replace 95/46/EC has been introduced in 
January 2012 with a target adoption date in 2014 and being effective in 2016 
after two year transfer period.  
 
This new General Data Protection Regulation (EC 2012) will be aimed against 
the privacy challenges from rapid technology evolvement including social 
media and cloud computing. The regulation “extends the scope of the EU data 
protection law to all foreign companies processing data of the EU residents” 
(New draft European data protection regime 2012).  
 
In the draft proposal there will be new privacy rights for EU citizens.  
 
The “right of portability” will allow a transfer of all data from one 
provider to another upon request, for example transfer of a social 
media profile or email, whereas the “right to be forgotten” will allow 
people to wipe the history clean (New draft European data protection 
regime 2012). 
 
 
 
4.2.3 US-EU Safe Harbor 
 
Safe Harbor framework has been created by US department of commerce in 
order to streamline US based companies’ privacy and personal data handling 
compliance with the 95/46/EC directive. If a US based company fulfills the 
requirements set by the Safe Harbor framework it has sufficient level of 
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processing EU citizen personal data and can operate in areas applicable for 
95/46/EC.  
 
For example corporations doing business within the EU cannot send personal 
data outside the EU unless there is at least equal level of privacy data 
protection. Safe Harbor compliance has been determined to comply with 
requirements by EC Commission with decision 2000/520/EY (EC 2000)  
 
US based organizations have a checklist for joining the Safe Harbor provided 
by US department of commerce  
 
It is critically important that an organization read the U.S.-EU Safe Harbor 
Privacy Principles, 15 FAQs, and enforcement documents before submitting a 
self-certification form (U.S.-EU Safe Harbor homepage 2013). 
 
List of Safe Harbor compliant companies is publicly available on Export.gov 
website. At the time of the writing (September 2013) there are 4130 US based 
companies. 
 
Recently there has been criticism against the safety of Safe Harbor 
compliance due to raised concerns of internet surveillance by the US National 
Security Agency. The German Conference of Data Protection Commissioners 
has urged to “suspend agreements that allow European companies to transfer 
personal data of European citizens to the U.S.” because of “mass surveillance 
of communications by the U.S. National Security Agency” (Essers 2013) 
 
4.3 Good Automated Manufacturing Practice (GAMP) 
 
GAMP is a set of guidelines published by International Society for 
Pharmaceutical Engineering (ISPE). GAMP is an evaluation guide to ensure 
that pharmaceutical company has sufficient quality for drug manufacturing by 
covering all areas of production. This covers materials, facilities, equipment, 
training aspects and even hygiene of the staff. At the time of the writing 
(September 2013) latest version of the GAMP guide is version 5, published in 
2008. 
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From IT point of view GAMP5 guide sets for example a framework for 
software validation by categorizing software into five classes. GAMP class 1 is 
classified being low risk category whilst category 4 and 5 are higher risk 
categories requiring code validation and life-cycle requirements (Martin & 
Perez 2008). GAMP defines operating system and utilities such as 
middleware part of the IT infrastructure. 
 
   
Figure 3 – GAMP4 and GAMP5 software categories (Martin & Perez 2008). 
 
Off-the shelf type of software such as office software products fall into 
category 3. 
 
GAMP5 guide provide tools for assessing risks by using factors such as 
severity, probability, detectability and risk class to form  
a) Risk class = severity * probability 
b) Risk priority = risk class * detectability 
 
These can be used in assistance for mitigating IT risks. 
 
4.4 ISO/IEC  
 
4.4.1 ISO/IEC 27001:2005 Information security management 
systems 
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This standard was approved in the year 2002 by BSI and later adopted by 
ISO/IEC in the year 2005. It is currently being revised and the new version is 
estimated to be available in the year 2013.  
 
The scope of the standard is to provide set of specifications of which 
organizations may use in seeking certification for their information security 
management systems. It has 8 sections that define ISMS requirements, 
management responsibilities, internal ISMS audits, management review of the 
ISMS and continuously improvement of ISMS. 
 
Approximately 1000 organizations are certified every year by accredited 
certification auditors making total amount of certified organizations to 7940 
(August 2012). Notably more than half of organizations are Japanese whilst 
no ISO/IEC 27001:2005 certified Finnish organizations are present 
(International Register of ISMS Certificates 2012) 
 
There are cloud computing service providers which have obtained ISO/IEC 
27001:2005 certification for their ISMS. Amazon Web Services LLC (platforms 
Amazon EC2, Amazon S3 and Amazon VPC) and Microsoft Global 
Foundation Services Windows Azure platform have received the certificate 
among others. 
 
4.4.2 ISO/IEC 27002:2005 Code of practice for information security 
management 
 
This standard was approved in the year 2005. It was previously known as 
ISO/IEC 17799:2005 but was renamed to ISO/IEC 27002:2005 in the year 
2007 in order to import it to the 27000 standard series. Wording of remained 
identical. 
ISO/IEC Secretariat JTC1/SC27 is currently revising the standard and it has 
been estimated that new version will become published in the year 2013  
 
ISO/IEC 27002 has 15 sections which have total of 39 control objectives for 
information security management. As an example the standard defines 
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business continuity as a section which includes two control objectives for 
resilience and disaster recovery. 
 
 
Figure 4 – ISO27002 (ISO27001 Security 2013) 
4.4.3 ISO/IEC 27017 Security in cloud computing (DRAFT) 
 
This standard is currently in 20.20 preparatory stage at the time of writing 
(September 2013). It is based on upcoming revision of ISO/IEC 27002 and the 
working title is “Guidelines on Information security controls for the use of cloud 
computing services based on ISO/IEC 27002”.  
 
The standard is expected to provide more cloud computing specific security 
control recommendations than ISO/IEC 27002. 
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4.4.4 ISO/IEC 27018 (DRAFT) 
 
This standard is currently (September 2013) in 30.20 committee stage. 
ISO/IEC Secretariat JTC1/SC27 is currently creating the standard with 
working title “Code of practice for data protection controls for public cloud 
computing services”. 
 
Mitchell lists the following content of the upcoming standard: 
  
•Objective is to collect and organize security categories and their 
controls from current data protection regulations.  
•Help public cloud service providers to comply with their obligations and 
make this transparent to their customers.  
•Customers can select cloud-based data processing services that allow 
them to meet their obligations.  
 
4.4.5 ISO/IEC 27036-x Information security for supplier 
relationships (DRAFT) 
 
This standard is going to be divided into several standards from 27036-1 
through 27036-5. Standard will define how to evaluate and mitigate security 
risks when using IT services or information supplied by 3rd parties. 
27036-1 Overview and concepts (1st draft available) 
27036-2 Common requirements (1st draft available) 
27036-3 Guidelines for ICT supply chain security (1st draft available) 
27036-4 Outsourcing (pre-draft) 
27036-5 Guidelines for security of cloud services (pre-draft) 
 
4.4.6 ISO/IEC 14971:2012 Application of risk management to 
medical devices 
  
This standard provides risk management tools for helping manufacturers to 
introduce medical devices on the market. Standard is not just for medical 
devices but it can be utilized by pharmaceutical companies also from risk 
management process point of view. 
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Standard introduces four steps for risk management process: risk analysis, 
risk evaluation, risk control and production and post-production information.  
 
4.5 Quality risk management (ICH Q9) 
 
European Medicines Agency (EMA) has released a guideline document for 
quality risk management called ICH Q9. The guideline provides qrm tools 
such as processes and examples for various aspects of pharmaceutical 
quality. The guideline presents a model of initiating a qrm management 
process via risk assessment, risk control, risk communication and risk review.  
 
The question of a quality risk may become significant for pharmaceutical 
products and therefore it is important to mitigate those risks on computerized 
systems. 
 
4.6 Summary 
 
A pharmaceutical company must follow several regulations starting from 
national legislation. Also several guidelines, tools and standards have been 
released which can be helpful in running good business practices. It is 
important to recognize the various aspects of regulations especially if 
company operates in several countries. 
 
European Union has paid attention to privacy and companies seeking for 
cloud based option should double-check to these privacy requirements. 
Recent skepticism on effectiveness of the safe harbor agreements caused by 
the espionage claims may lead into major revision of the agreement. 
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5 CLOUD COMPUTING IN PHARMACEUTICAL INDUSTRY 
 
The question of using cloud based applications in pharmaceutical industry is 
complicated and requires multiple levels of analysis. Various applications, 
data, GMP significance, cloud deployment models and difference between 
pharmaceutical companies does not justify simple “yes” or “no” conclusions for 
cloud computing suitability. The following gathers some of the factors affecting 
to the decision making.  
 
5.1 Applications types 
 
The most important question related to outsourcing applications to cloud is the 
potential impact to the GMP significant applications (Stokes 2012, 66).  
 
Standard office products, communication tools, financial systems are typically 
classified to non-GMP applications unless a connection to GMP data exists. 
GMP significant applications may include customer relationship management 
(CRM), enterprise resource planning (ERP), statistical analysis software, 
laboratory inventory management software (LIMS) and various other types of 
software which have direct access to GMP data.  
 
Pharmaceutical organization considering usage of cloud based applications in 
any form should perform an application classification in order to identify 
regulatory requirements. It is recommended of performing initial 
implementations with low-risk systems to minimize failure impacts 
 
Any new technology or new approach to IT solutions presents 
risks. Even if the technical risks have been evaluated and addressed, 
there is a risk that the procedural controls (e.g., security controls, staff 
training, and validation) will be lacking or just challenged by the 
authorities because they are different from traditional approaches 
(Gorban 2012) 
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5.2 Data types 
 
Pharmaceutical industry can generate various types of data such as clinical 
trial data, IP information, work instructions, batch manufacturing records, 
certificates, finance data, personal information etc. which all may have 
different frameworks and regulations for data handling. Extensive reviews of 
regulation requirements should be done if electronic records of GMP relevant 
data will be stored in a cloud based solution. GMP relevant data may also 
include spreadsheets and databases. 
 
Data classification is a vital process before any data should be stored in any 
cloud based system. An example of steps for the data classification has been 
defined:  
 
1. Identify the data that will be processed or stored in the cloud. 
2. Classify the information in regards to sensitivity towards loss of the CIA 
criteria. This would include identifying regulatory requirements for the 
data. 
3. Define the rules by which particular information classes of instances 
must be stored, transmitted, archived, transported and destroyed. Many 
handling requirements result from contractual or regulatory 
requirements.  
(Cox 3-4) 
 
5.3 Layers or responsibility  
 
When evaluating cloud implementation options from regulatory point of view it 
is important to underline the different layers of responsibility of each 
deployment model. IaaS gives much more flexibility for the end user whereas 
SaaS usually requires the least of administration for the system. Carstensen 
et al. (2012) illustrates in figure 5 a so called trust boundary which defines 
responsibilities of service user and service provider. Trust boundary separates 
the responsibility of application, OS/middleware and infrastructure layers in 
IaaS, PaaS and SaaS deployment models. For example in SaaS application, 
OS/middleware and infrastructure is responsibility of the service provider but 
in IaaS infrastructure only is service provider’s responsibility. 
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Figure 5 – Trust boundary (Carstensen et al. 2012). 
 
Also the question of public or private clouds must be evaluated - is the 
platform private or public? Who is in charge or security administration for the 
cloud? 
 
It has been recommended that in a phased approach model provider’s 
responsibilities (in IaaS) to be limited below operating system level because    
 
Providers often implement the appropriate security and data protection 
controls, but FDA requirements for formal qualification, training, and 
documentation are unlikely to be met.  Risks can be minimized by 
keeping the responsibilities for the standard Operating System, 
middleware, and applications in house (Gorban 2012) 
 
5.4 Agreements and accountability  
 
Formal agreements are mandatory between customer and service providers. 
This requirement is defined in Annex 11  
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When third parties (e.g. suppliers, service providers) are used e.g. to 
provide, install, configure, integrate, validate, maintain (e.g. via remote 
access), modify or retain a computerised system or related service or 
for data processing, formal agreements must exist between the 
manufacturer and any third parties, and these agreements should 
include clear statements of the responsibilities of the third party. IT-
departments should be considered analogous (EC 2011). 
 
According to Stokes (2012, 5) regulated company is always accountable to 
the regulatory authorities for  
 
- The appropriate control and compliance of their IT infrastructure (IaaS 
and PaaS) 
- The validation of the GxP significant applications (SaaS) 
 
However, “day to day” responsibilities can be outsourced.  
 
5.5 Vendor audits 
 
Pharmaceutical companies must assess supplier for adherence to regulatory 
and business requirements. It is the responsibility of pharmaceutical company 
to make sure their service provider meet the appropriate compliance 
standards. With regards to service provider assessment approach Annex 11 
state  
 
The competence and reliability of a supplier are key factors when 
selecting a product or service provider. The need for an audit should be 
based on a risk assessment (EC 2011). 
 
Supplier assessment can be done by questionnaires (offline, online or 
assisted), performing an on-site audit (data center, support office) or by using 
a 3rd party assistance with an auditing standard such as SAS 70 or SSAE-16. 
Once a supplier has been accepted there might become need to do re-
evaluation at some point. GxP compliance issue or a system upgrade could 
indicate a need to re-assess the supplier. 
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Questionnaire for hosting and managed services apply, some additional cloud 
specific questions and explanation requests should be included. In the 
following examples of such questions have been listed: 
 
- Issues of access via uncontrolled networks 
- Need to qualify and validate for a broad range of client devices 
- The uncontrolled nature of “self-service‟ (process owners 
provisioning inappropriately qualified, validated or controlled it 
infrastructure, platform’s or applications) 
- Resource pooling (shared access) erodes one or more layer of 
security controls 
- Location independence may not be bounded 
- Rapid elasticity may undermine necessary change controls  
(Stokes 2012, 32) 
 
In addition questions like these may be relevant for pharmaceutical industry: 
 
- Application can move inside a datacenter but what about between 
the datacenters? 
- Where does the data physically reside? 
- How can I make electronic copies of my regulatory critical records? 
- How is my data backed up? 
- What kind of disaster recovery arranagement are in place? 
- If I make a mistake can you restore just my data? 
- How can I remove/get back my data if I choose to de-cloud? 
 
5.6 Validation and qualification 
 
It is important to recognize the difference between validation and qualification 
because regulations refer to both terms. EudraLex Volume 4 Annex 11 states 
“The application should be validated; IT infrastructure should be qualified.” 
(EC 2011)  
 
Rajinderkaur (2008) describes the difference of validation and qualification; 
 
Qualification is a process of assurance that the specific system, 
premises or equipment are able to achieve the predetermined 
acceptance criteria to confirm the attributes what it purports to do.  
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Validation is establishing a documented evidence to provide a high 
degree of assurance that a specific system, process or facility will 
consistently produce a product meeting its predetermined specifications 
and quality attributes. 
 
Things are qualified: equipments, systems etc. 
Process/Procedures (the way we use things) are validated. 
 
Requirements for application validation in cloud based applications do not 
differ from standard networks. Decision of software validation will have to be 
made through appropriate frameworks and regulatory guidelines.  
 
Karamanova (2012, 19) advices to create a checklist with questions on the 
impact of computerized systems to drug product quality. Validation is required 
if at least one answer is yes on the checklist. 
 
5.7 Sector targeted cloud solutions 
 
IT infrastructure qualification, application validation requirements and other 
requirements set by various regulations may lead into cumbersome scenarios 
when a pharmaceutical company seeks a cloud based solution for their GMP 
significant applications. For example lack of audit trails or forced application 
upgrades on SaaS may come as a surprise if the requirement has not been 
noted in the evaluation phase. Therefore cloud computing industry has shown 
signs of waking up to the sector specific needs.  
 
There are cloud solutions available targeted directly to pharmaceutical and life 
sciences industry which provide compliant platforms. One example is 
Compliance Cloud by NextDocs Corporation. Traditional SaaS platform offers 
a multi-tenancy on the application layer whereas Compliance Cloud provides 
multi-tenancy on the infrastructure level. “Each customer gets a fully logically 
isolated environment consisting of dedicated virtual web, application and 
database servers” (NextDocs 2012). Virtual servers, databases, network and 
resources is said to provide isolation from other customers and enable 
freedom in application upgrades – upgrades are not mandatory. Company 
claims regulatory compliance and validation readiness  
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The NextDocs Compliance Cloud was designed and implemented to be 
validation ready. Each customer environment includes Development, 
QA and Production environments in support of Change Control 
practices. Our operational and support processes are implemented to 
be compliant with regulations and optimized to follow industry best 
practices. We recognize the complexities of compliance in the cloud 
and have addressed those challenges in the architecture of the 
NextDocs Compliance Cloud, in the NextDocs products, and in our 
operational and support processes. (Nextdocs 2012) 
 
Another example of sector targeted product is EMC Cloud Computing 
Solutions for Life Sciences consultancy and regulation compliant systems 
based on a private cloud.  
 
EMC Consulting will enable you to build a qualified infrastructure, 
validate your applications, and develop a risk management strategy to 
ensure you can use private cloud to support and enable your regulated 
applications. We start by determining which aspects of the IT 
Infrastructure to qualify and the required extent of that qualification. We 
then validate applications using established and enforced corporate 
policies to define the overall approach to computerized system quality 
and compliance (EMC 2011). 
 
5.8 Where to start – support documentation 
 
The following organizations have prepared documents and guidelines to assist 
in the cloud decision making and vendor evaluation process. 
 
5.8.1 CSA 
 
Cloud Security Alliance (CSA) is a not-for-profit organization consisting of 
cloud key stakeholders that promotes the use of best security practices within 
cloud computing. CSA has published two publicly available documents that 
any organization approaching cloud based solutions may find useful  
 
- Consensus Assessments Initiative Questionnaire  
- Cloud Controls Matrix Framework 
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5.8.2 ENISA 
 
European Union Agency for Network and Information Security (ENISA) is 
responsible for cyber security issues affecting to EU. Organization’s goal is to 
achieve good quality of network and information security within EU. ENISA 
has published on their web site a lot of documentation that can help in the 
decision making process such as  
 
- Reports on cloud computing 
- Cloud computing information assurance framework 
- Cloud computing risk assessment  
 
5.8.3 NIST  
 
National Institute of Standards and Technology (NIST) is an US based federal 
agency to promote US industrial competitiveness. Cloud computing relevant 
material include  
- NIST Special publication 500-293, US Government Cloud Computing 
Technology Roadmap, Release 1.0 Volume 1 and Release 1.0 Volume 
2 
 
5.8.4 ISACA 
 
ISACA is a nonprofit global association to promote knowledge and practices 
for information systems. They have release the following documents which 
may be useful in the cloud computing evaluation process 
 
- Cloud Computing: Business Benefits With Security, Governance and 
Assurance Perspectives 
- IT Control Objectives for Cloud Computing: Controls and Assurance in 
the Cloud 
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5.9 Block level approach  
 
If a pharmaceutical company selects for instance IaaS as their base model for 
implementing cloud services there are usually many options of approaching 
the question of responsibility depending on the application configuration. 
Application can be made available for example using following methods  
 
1. Internal application hosted on IaaS (VMware or Amazon etc.)  
2. External application hosted on third party IaaS  
3. External application hosted on application providers own 
infrastructure  
4. True multi-tenant application (shared dbase etc.) hosted on third 
party IaaS  
5. True multi-tenant application hosted on providers own infrastructure 
(Appendix 1) 
 
These different configurations can be broken into blocks and understand 
where the different layers of responsibilities are. For example IaaS border is 
located at the operating system level and therefore question of validation may 
become obsolete as GAMP4 and GAMP5 guides categorization classifies 
operating systems on software category 1. Instead a platform qualification is 
expected.  
 
5.10 EudraLex 4 Annex 11 cloud computing specific clauses 
 
Eudralex 4 Annex 11 has seventeen clauses. In addition of previously 
mentioned application validation, infrastructure qualification and vendor audit 
requirements there are several others that need to be taken into account 
during cloud computing evaluation. In table 1 most relevant ones to cloud 
computing have been handpicked. 
  
TABLE 1. EudraLex 4 Annex 11 cloud computing specific clauses (EudraLex 
2011) 
 
Annex 11 clause Requirement 
1. Principle  1. The application should be validated; IT infrastructure 
should be qualified. 
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2. Personnel 2. All personnel should have appropriate qualifications, 
level of access and defined responsibilities to carry out 
their assigned duties. 
3. Supplier and 
service provider 
3.1 When third parties (e.g. suppliers, service providers) 
are used e.g. to provide, install, configure, integrate, 
validate, maintain (e.g. via remote access), modify or 
retain a computerised system or related service or for 
data processing, formal agreements must exist between 
the manufacturer and any third parties, and these 
agreements should include clear statements of the 
responsibilities of the third party. IT-departments should 
be considered analogous. 
 
3.2 The competence and reliability of a supplier are key 
factors when selecting a product 
or service provider. The need for an audit should be 
based on a risk assessment. 
7. Data storage 7.1 Data should be secured by both physical and 
electronic means against damage. Stored data should 
be checked for accessibility, readability and accuracy. 
Access to data should be ensured throughout the 
retention period. 
 
7.2 Regular back-ups of all relevant data should be 
done. Integrity and accuracy of backup data and the 
ability to restore the data should be checked during 
validation and monitored periodically. 
9. Audit trails 9. Consideration should be given, based on a risk 
assessment, to building into the system the creation of a 
record of all GMP-relevant changes and deletions (a 
system generated "audit trail"). For change or deletion 
of GMP-relevant data the reason should be 
documented. Audit trails need to be available and 
convertible to a generally intelligible form and regularly 
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reviewed. 
10. Change and 
configuration 
management 
10. Any changes to a computerised system including 
system configurations should only be made in a 
controlled manner in accordance with a defined 
procedure. 
12. Security 12.1 Physical and/or logical controls should be in place 
to restrict access to computerized system to authorised 
persons. Suitable methods of preventing unauthorised 
entry to the system may include the use of keys, pass 
cards, personal codes with passwords, biometrics, 
restricted access to computer equipment and data 
storage areas. 
13. Incident 
management 
13. All incidents, not only system failures and data 
errors, should be reported and assessed. The root 
cause of a critical incident should be identified and 
should form the basis of corrective and preventive 
actions. 
16. Business 
continuity 
16. For the availability of computerised systems 
supporting critical processes, provisions should be 
made to ensure continuity of support for those 
processes in the event of a system breakdown (e.g. a 
manual or alternative system). The time required to 
bring the alternative arrangements into use should be 
based on risk and appropriate for a particular system 
and the business process it supports. These 
arrangements should be adequately documented and 
tested. 
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5.11 Summary 
 
Cloud computing in pharmaceutical industry is not a simple topic due to 
complexity of different cloud deployment models and layers of responsibilities. 
It is important to identify GMP significant features of operations as per 
Eudralex 4 Annex 11. Therefore the sector specific cloud solutions may 
become more popular among industry. The subject of vendor assessment can 
be approached block by block using the assistance of documents released by 
various organizations such as CSA.  
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6 SECURITY 
 
6.1 Security issues 
 
Survey after surveys among information technology management shows 
security being top issue preventing larger scale utilization of cloud computing. 
In a survey among CIOs (Cloud Adoption Study: Cloud computing is gaining 
momentum 2011) insufficient data security was ranked number one reason for 
not adopting cloud computing.  
 
Security as a term can for example include elements of application, network, 
data, service or instance security. 
 
By definition of Wikipedia (Cloud computing security 2013) security issues 
associated with cloud computing can be split into two categories; 
1. Security issues faced by cloud providers 
2. Security issues faced by their customers 
 
According to Wikipedia (Cloud computing security 2013), in most of the cases 
it is the responsibility of the service provider to secure their infrastructure 
among end-user data. It is the responsibility of customer to ensure that service 
provider has implemented the proper security measures. 
 
Wang (2009) evaluates cloud security from three aspects; 
1. Security and privacy (i.e. disaster recovery) 
2. Compliance (i.e. proper handling of audit trails) 
3. Legal and contractual issues (i.e. liabilities) 
 
6.2 Security controls 
 
For cloud service providers to manage security issues proper security controls 
need to be in place. Francis (2013) lists four categories with examples for 
cloud security controls;  
1. deterrent (i.e. logon warnings to advice users of rights to enter system) 
2. preventative (i.e. installing a proxy server ) 
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3. corrective (i.e. quick change of passwords after an incident) 
4. detective (i.e. testing unlawfully access to information)  
 
6.3 Security assessment 
 
As a part of vendor assessment a security assessment may be performed to 
document what security controls are in place in a cloud platform. As a 
template, a questionnaire titled “Consensus Assessments Initiative 
Questionnaire” (2011) has been released by the Cloud Security Alliance for 
the use of cloud auditors and customers. The purpose of the questionnaire is 
to provide more transparency within industry. Each question has a framework 
of certain regulations (i.e. ISO27001) in which they refer to. For example 
questionnaire item DG-07.1 about information leakage in a multi-tenant 
environment refers to sections A.10.6.2 and A.12.5.4 of ISO27001 and may 
be directly suitable in use of multi-tenant pharmaceutical SaaS software 
evaluation. 
 
6.4 Securing the data 
 
Anytime when data moves outside of the traditional IT infrastructure there is a 
potential risk of jeopardizing sensitive content. Why not use best possible 
cryptography technology at every node? Usually there might be performance 
issues if data is being encrypted at rest, in process and in motion.  
 
Cloud Security Alliance lists three options for securing the data transmission; 
Client/Application encryption, Link/Network encryption and proxy-based 
encryption. CSA recommends of encrypting data at the network level on every 
deployment models. CAS also documents how data can be encrypted in 
different cloud deployment models (Security Guidance for Critical Areas of 
Focus in Cloud Computing 2011) 
 
According to HIPAA § 164.312 data encryption when handling regulated data 
in transit is mandatory.  
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Implement technical security measures to guard against unauthorized 
access to electronic protected health information that is being 
transmitted over an electronic communications network. (HIPAA 
Technical Safeguards) 
 
Vendors like Symantec providing cloud based products have addressed to the 
sector specific requirements explaining how their online backup product 
complies with HIPAA regulations.  
 
While there is no standard HIPAA certificate of compliance for online 
backup services, Symantec Protection Network (SPN) enables HIPAA 
defined covered entities that must store &protect electronic patient data 
comply with HIPAA security and privacy rules by: 
 
• Encrypting data at the point of origin, during the backup process, using 
256-bit AES (approved by the NSA for encrypting U.S. classified data 
up to and including Top Secret). 
• Encryption key is private which only the originator (not even Symantec) 
has access 
• All information is sent through a secure 128-bit SSL tunnel to one of the 
Symantec datacenters. 
• Symantec data centers and operations are SAS-70 Type II certified. 
Additionally SPN follows an ISO 17799 / 27002 security framework and 
ITIL Service Management framework. 
(Is Symantec Online Storage HIPAA Compliant? 2008) 
 
6.5 Risks 
 
Cloud computing in itself does not differ from traditional computing from risk 
point of view. There are some unique risks however. For instance access to 
computerized systems via uncontrolled networks and using resource pooling 
are unique compared to traditional computing. Also the type of chosen cloud 
platform together with chosen deployment model gives different risk variables. 
Therefore extra attention is required in risk assessment and mitigation.  
 
Carstensen et al. (2012, 39) describes a method to understand interaction 
between risk, security and compliance in cloud based environment. An 
important thing to notice is that in the areas of compliance and security cloud 
user and cloud provider both have some of the responsibility. In the area of 
risk there is not usually similar boundary because of wide utilization of 
asymmetric risk arrangements in the agreements. Risk of lack of application 
37 
 
availability for instance results usually to financial penalties but only in limited 
amount. 
 
IT risk measurement has been defined by Wikipedia (IT risk management 
2013) “The measure of a IT risk can be determined as a product of threat, 
vulnerability and asset values: Risk = Threat * Vulnerability * Asset” 
 
6.5.1 Cloud model risks 
 
Selected cloud computing model also has an important part in the evaluation. 
According to Stokes (Figure 6) private IaaS cloud deployed on-premises has 
far less variables and connection points through uncontrolled networks 
compared to public SaaS cloud deployed off-premises. This of course 
depends on the implementation of the system; it may become useful to 
classify risks into three categories of acceptable, controllable and 
unacceptable (Stokes 2012, 33). 
 
Figure 6 – Risk continuum dimensions (Stokes 2012, 34) 
 
The risk can also be mitigated by having a fully test disaster recovery plan and 
procedures in place. 
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6.6 Risk assessment 
 
Risk assessment is mandatory by many (Pharmaceutical) compliance 
standards such as EudraLex Volume 4 Annex 11, PCI DSS requirement 
12.1.12, HIPAA section 164.308(a) (1) and ISO27001 Clause 4.1. If risk 
assessment is not mandatory from compliance point of view it is still 
considered to be good business practice and there are business rationales 
that benefit from risk assessment. 
 
Before starting the risk assessment the business model company or 
organization currently has should be identified first. This context establishment 
is used as an input for risk analysis. 
 
There are various methodologies like “NIST SP 800-30” or “Octave” for 
performing a structured risk assessment. One possible risk assessment option 
in evaluating cloud computing systems is the “ISO27005:2011 Information 
security risk management” standard. It has three steps: identification, 
estimation and evaluation of risks. 
 
1. According to Wikipedia (IT risk management 2013) ISO27005 advices 
to identify in risk identification phase the following list of causes of a 
potential loss: Assets, threats, security measures (existing and 
planned), vulnerabilities, consequences and related business 
processes.  
2. Risk estimation phase specifies the measure of risk: quantitative 
(mathematically calculated) and qualitative approach (evaluation from 
low to very high). Risk estimation produces a list of risks with values 
which can be formatted into a risk list. 
3. Risk evaluation phase prioritizes and compares the identified risks 
based on risk evaluation and acceptance criteria.  
 
6.7 Risk mitigation 
 
Risks in IT are part of normal business operations. It is impractical and 
extremely expensive to eliminate all risks. However it is usually possible to 
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reduce risks. If risk assessment process reveals major findings then risk 
mitigation should to be implemented. Different tools can be used in assistance 
to mitigate the risks. A failure mode and effect analysis (FMEA) is a common 
tool that uses risk assessment - or similar analysis - as an input and generates 
either risk severity reduction or lowering the probability of the risk. 
  
A successful FMEA activity helps to identify potential failure modes 
based on past experience with similar products and processes or 
based on common failure mechanism logic. It is widely used in 
development and manufacturing industries in various phases of the 
product life cycle (Failure mode and effects analysis 2013) 
  
Organization can be highly affected if the chosen cloud platform is not 
accessible. This risk can be mitigated by selecting correct service level 
agreement (SLA) with appropriate uptime category. So called class of 9s is 
widely used in the SLAs where 90% equals to maximum of 36,5 days of 
downtime in a year, 99,99999% maximum of 3,15 seconds of downtime in a 
year.  
 
6.8 Summary 
 
The elimination of all risks is expensive and very impractical. Cloud computing 
is not an exception and has risks which needs to be addressed adequately. 
There are also risks explicit to cloud computing. Vendors have started to 
release documentation to support decision making by showing how their 
products are compatible with various regulations.    
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7 RISK BASED APPROACH MODEL 
 
7.1 Background 
 
In order to achieve fuller understanding of regulations and cloud computing in 
pharmaceutical industry a risk based approach model has been generated to 
show real-life connections between the good manufacturing practices, 
regulations and technology.  
 
In the previous chapters the terminology for cloud computing has been 
introduced together with relative ISO/IEC standards, general EU directives, 
security issues, sector specific regulations and other guidelines.  
 
This risk based approach model has been based on pharmaceutical company 
point of view. It can be utilized as a case study template for companies 
seeking for cloud computing solutions. 
 
7.2 Introduction 
 
As learned in previous chapters it is vital for pharmaceutical companies to 
identify computerized operations within organizations that may have GMP 
significance. It is also required to act on findings with appropriate actions to 
mitigate the risks. Failing to do so may result failures in audits, official warning 
letters, financial penalties and even seizures of operations. 
 
Even if GMP significant features mentioned in the EudraLex Volume 4 Annex 
11 of software or a system have been recognized earlier it may be useful to 
revisit those findings especially if any cloud based solution models are in 
consideration. Also as personnel may have changed over the years and 
change logs do not necessarily provide accurate information whether any 
custom modification has been made to standard off-the-shelf type of software 
application. 
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7.3 Risk based approach model 
 
In this model there are six steps starting from gathering operational data and 
identifying GMP significant features and resulting in decision on cloud 
suitability for selected application. 
 
 
Figure 7 – Risk based approach model steps  
 
The following steps have been identified as required steps based on risk 
management approaches on GAMP 5, ICH Q9 and ISO 14971 guidance. 
 
1. Gather operational data 
o Input: Interviews, User requirement specifications (URS) 
o Output: System description (SD) 
 
2. Identify GMP significant features of software application 
o Input: SD, regulations and guidelines 
o Output: GMP impact assessment (GMPIA) 
 
 
3. Calculate risk priority numbers for GMP significant features 
o Input: GMPIA 
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o Output: Failure mode effect analysis (FMEA) 
 
4. Mitigate high risk priority number (RPN) risks 
o Input: FMEA 
o Output: Updated FMEA 
 
5. Evaluate the risks whether they excess limits 
o Input: Updated FMEA  
o Output: Risk assessment (RA) summary 
o Output: Data for cloud computing decision making 
 
6. Decision making 
o Input: RA summary 
o Output: Final decision and path of proceeding 
 
Framework in table 2 reflects these six steps with relevant sections of GAMP 
5, ICH Q9 and ISO 14971 processes. 
 
TABLE 2. Risk based approach model framework 
Step GAMP 5 ICH Q9 ISO 14971 
Gather operational data Step 1 Initiate QRM process - 
Identify GMP significant 
features of software application 
 
Step 2 
 
Risk identification 
 
Risk analysis 
Calculate risk priority numbers 
for GMP significant features 
Step 3 Risk analysis and 
evaluation 
Risk evaluation 
Mitigate risks with high risk 
priority numbers (RPN) 
Step 3 Risk reduction 
 
Risk control 
Evaluate the risks whether they 
excess limits 
Step 4 Risk acceptance 
 
Evaluation of overall 
residual risk 
acceptability 
Decision making Step 5 Risk communication 
 
Review events 
Post production 
information 
 
7.3.1 System description (SD) 
 
System description is a document describing main features of a system and 
how they are utilized in practice. The format of the document can be created 
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to fulfill the specific needs or to follow possible corporate layout template. In 
general the contents vary depending on what is appropriate. In this example it 
is necessary to list main modules of the ERP software and modifications to 
these modules to-date.  
 
An example of modifications made to the software code in a module: 
 
Stock items can be receipted into the company against an approved purchase 
order. The user will check that the delivery meets the order conditions, 
recording the receipt in ERP and assigning a batch number and expiry date (if 
required).  If required labels and a material reception and release form are 
printed. Stock items are receipted into the quarantine location.   
 
The following modifications have been made:  
• Add two fields on the PO line receipt form that requires a user to 
denote whether a batch certificate has been received with the order and 
whether it complies with the order requirements. These are only displayed if 
the ‘PO Manuf. batch certificate fields req, flag is set on the company card. 
• Print storage temperature from item card on receipt labels and material 
reception & release form.   
 
An example of no software modifications applied in a module: 
 
The Company card holds system wide information that is used throughout the 
modules (Company name, address, financial info etc.). 
 
The following modifications have been made: - NONE. 
 
7.3.2 GMP impact assessment (GMPIA) 
 
GMP impact assessment should be generated to identify software application 
features that may have GMP significance. The layout of the document is free 
and it may include elements such as list of software features and their GMP 
significance. An example of a GMPIA document template has been attached 
as per appendix two. 
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In general high GMP impact systems typically include those that: 
- Generate, manipulate, or control data supporting regulatory safety and 
efficacy submissions 
- Control critical parameters or data used at any stage; clinical, development 
and manufacture 
- Control or provide data for product release 
- Control data required in case of product recall 
- Control adverse event or complaint recording or reporting 
- Support pharmacovigilance 
 
7.3.3 Failure mode effect analysis (FMEA) 
 
Using tool such as FMEA or similar, the value of a risk can be mathematically 
calculated and evaluated further.  It may become useful to analyze different 
“what if” –scenarios if applications and functionalities are actually being placed 
in a cloud service.  
 
FMEA is a subjective screening tool to calculate risk priority numbers with 
highest number of having the biggest risk. Risk priority number can be 
calculated with a formula of RPN = Severity (on a scale of 1 to 10) * 
Occurrence (on a scale of 1 to 10) * Detection (on a scale of 10 to 1). An 
example FMEA template can be found from Appendix 3. 
 
7.3.4 Risk assessment summary 
 
High risks with GMP significance identified with FMEA can be mitigated by 
elimination, reducing to suitable level or by demonstrating that the levels are 
suitable with an extended review. In the risk assessment the high risks are 
being addressed using preventative corrective actions and the RPN numbers 
for the risks are recalculated.  
 
Risk assessment summary document summarizes GMPIA and FMEA 
findings, preventative risk mitigation actions and lists final RPN numbers. 
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Document gives data for cloud computing decision making on systems that 
have GMP significance.  
 
7.4 Summary 
 
Risk based approach model was created as an example due to various 
similarities in GAMP 5, ICH Q9 and ISO/IEC 14971 guidelines. This approach 
model can be used as a template for any company seeking for a cloud based 
solution.    
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8 CONCLUSION AND RECOMMENDATIONS 
 
Pharmaceutical companies need to follow regulatory guidelines, most 
importantly in Europe EudraLex Volume 4 Annex 11. This directive clearly 
states that the software should be validated and IT infrastructure should be 
qualified.  
 
Therefore regulated companies need to validate their GMP significant 
applications whether they are based on their own server infrastructure, on or 
off premise cloud platform or otherwise outsourced. Using public cloud based 
software applications that are not GMP significant is more of a business 
decision and should involve all the relevant stakeholders. This category may 
include for example communication software. 
 
The qualification of the IT infrastructure is mandatory regardless of chosen 
service deployment model. Qualification needs to be documented.  
 
However, as long as certain expectations are fulfilled cloud computing should 
be an acceptable solution from regulatory point of view also for GMP 
significant applications. Before moving to public cloud the following steps need 
to be completed on satisfactory level: 
 
• Review applicable regulations  
• Determine cloud service type  
• Determine cloud deployment model 
• Perform application and data classification 
• Do vendor audits and qualifications 
• Perform risk assessments and mitigate risks 
• Review data security requirements  
• Perform infrastructure qualifications 
• Perform software validations 
• Start with least critical systems 
• Have fallback models in case of “de-clouding” at some point 
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There are different approach models. One, a phased risk based approach 
model was created in this thesis in chapter 7. It can be used to identify GMP 
significant features in software applications and in risk identification and 
mitigation processes.  
 
In conclusion private cloud and public IaaS are easiest to tackle from 
pharmaceutical regulatory point of view. Applications can be validated and 
infrastructure qualification performed as required.  
 
Off-premise SaaS, PaaS, community cloud and other “higher altitude of cloud” 
solutions like multi-tenant applications are a possibility but depending on 
implementation method they may not be in compliance with the regulations.  
Aspects like continuous software upgrades which affect application validation 
status or lack of audit trail could be directly against regulations. They may also 
require much more thoroughly vendor assessment and heavier risk 
assessment processes than simpler IaaS platforms. 
 
There have been some signs of cloud service industry waking up to the 
situation (Chapter 5.7.) and a few sector specific compliance cloud types of 
products have been rolling onto the market. If the cloud infrastructure in itself 
would be qualification ready (or pre-qualified) and applications could be 
validated it should lower the bar for pharmaceutical industry to enter the cloud 
era also in SaaS solutions. 
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APPENDICES  
 
Appendix 1  
 
An interview with N.N., Director of Sales EMEA at N.N. This interview was 
done via Linkedin social networking site using send and receive messages 
function in October 2012. 
 
To: N.N.  
Date: October 15, 2012  
--------------------  
Hi N.,  
 
I'm doing my thesis work on Cloud computing in Pharmaceutical industry and 
pretty confused at the moment. I have a couple of tough questions on the 
matter - could I please use your expertise?  
 
 
To: Ville Harjulampi 
Date: October 15, 2012  
--------------------  
Hi Ville,  
 
No problem, I'll do my best to give you an answer! The pharmaceutical 
industry is quite confused on the subject at the moment but in reality it's all 
quite simple. Just send the questions across.  
 
 
 
 
 
 
To: N.N.  
Date: October 15, 2012  
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--------------------  
Hi N.,  
 
thanks. I am familiar with the old school "server/client" type of network and 
application validation requirements. Especially if the software is standard off 
the shelf type. (Create URS, VP, protocols, validate and that's it!) Virtualization 
and cloud based thinking are not in itself giving me hard time - I do know the 
technical concepts of resources pooling, cloud service layers and how 
different cloud types differ. I've also been playing around with Hyper-V and 
VMWare solutions.  
 
How on earth should we tackle the challange of combining GMP regulated 
activities, regulations and cloud computing? For instance EudraLex Vol 4 
Annex 11 lists quite a few things to be taken into consideration starting from 
the principle "The application should be validated; IT infrastructure should be 
qualified".  
 
If a pharmaceutical company would like to use outsourced, let's say ERP 
system which has several GMP regulated activities what would be the correct 
marching order? How would it document and verity compliance with Vol. 11 
requirements?  
 
Vendor assessments may bit a bit difficult to perform as well as knocking on 
the door of a datacenter (if you even know what's the right continent :)  
 
Would it be the way of creating Risk Assessments, FMEAs, Impact 
Assessments etc. and documenting that using this and this application from 
cloud using a chosen service provider doesn't increase the overall risk 
compared to the current server/client model?  
 
 
 
 
To: Ville Harjulampi  
Date: October 15, 2012  
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--------------------  
Hi Ville,  
 
This is a question that we are all trying to understand still! There are a few 
different ways of looking at it.  
 
If you break down the cloud layers into IaaS, PaaS and SaaS that is the 
easiest method.  
 
We then generally see a few different combinations of these in delivering 
services.  
 
For example:  
 
Internal application now hosted on IaaS (VMware or Amazon etc)  
External application hosted on third party IaaS  
External application hosted on application providers own infrastructure  
True multi-tennant application (shared dbase etc) hosted on third party IaaS  
True multi-tenant application hosted on providers own infrastructure  
External application developed on PaaS (Force.com etc) where data center 
location is now known.  
 
The key thing is to try and break these all down into blocks and understand 
where the different layers of responsibility are.  
 
For example IaaS stops at the OS level so you would not expect to validate 
anything at IaaS but qualify it.  
 
The big thing that is happening in the market at the moment is whether for 
example an IaaS provide qualifies the infrastructure themselves. This would 
great reduce the costs if there was a standardised qualification for example 
across all vmware IaaS providers. This would also be greatly beneficial to the 
Pharma companies as most of the qualification work is already done.  
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Providers who are looking to provide to the Pharma market understand that 
where the data resides is also key and that they may have to start opening the 
doors of thei datacenters (we do and also ensure that the data only resides in 
these legal jurisdictions). What we may see happening though is cloud 
environments becoming more expensive for specific vertical markets if for 
example Pharma want the cloud providers to maintain large documented audit 
requirements (IQ/OQ and the rest of the quality/validation docs etc.  
 
You could write a whole these on this... 
 
 
To: N.N. 
Date: October 17, 2012  
 
Hi N.,  
 
thank you for your response. This is a very helpful view. I like the idea of 
breaking down to blocks and defining different responsibility layers.  
 
I think cloud service providers have seen the need to "endorse" their platforms 
from regulatory point of view. For instance Microsoft claims to be in 
compliance with following standards and regulations for their Dynamics CRM 
cloud product: Safe Harbor, ISO 27001, SAS70 Type II and FISMA.  
 
http://www.microsoft.com/online/legal/v2/?docid=27  
 
One thing I've been thinking to evaluate a cloud service provider is the Cloud 
Controls Matrix (CCM) framework provided by Cloud security alliance. You 
may have heard about the framework which can be downloaded from their 
web page:  
https://cloudsecurityalliance.org/research/ccm/  
 
Microsoft has done fantastic job in evaluating their Azure against the CCM 
matrix requirements. They've released a document on the subject (DOC, 
4MB)  
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http://download.microsoft.com/download/7/4/9/749DF9E9-4357-4A73-8FD8-
9602B1F7A2E1/StandardResponsetoRequestforInformationWindowsAzureSe
curityPrivacy.docx 
 
Like said this is a massively big area to investigate and I hope you don't mind 
if I come back on the subject at some point.  
 
To: Ville Harjulampi  
Date: October 18, 2012  
Hi Ville,  
 
The main problem is that the majority of the current certs don't transfer to 
Pharma very well. SAS70 is just a financial snapshot and doesn't really mean 
anything, Safe Harbor is really about protecting against the Patriot Act but 
again it's just a registration process and the Patriot Act itself is a bit of a red 
herring.  
 
ISO27001 one is a different standard again but it's really just procedural.  
 
You also have the G-Cloud intiative by the UK government and the Cloud 
Security Alliance as you mention.  
 
Really there needs to be a better standard for the Pharma industry to 
understand or a set of documents that shows the delta between the different 
standards.  
 
I'll see if I can find some of the presentations from the GAMP forum event a 
few weeks ago. There’s some interesting info in there.  
 
One other thing to think about is what is actually being protected. Clinical trials 
for example will now have people entering data in IPADS across the globe. 
The data is being sent across multiple network connections and geographies 
and there's no way to avoid this. But the data doesn't really mean anything to 
the end user, the value is when the data is collated and the algorithms 
applied. So really the only concern is at the point of computation in this case. 
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So if that's a central data center/cloud provider in a known location it becomes 
a lot easier to control.  
 
The other key is that the cloud platforms themselves are becoming more 
standardised. In IaaS there is really only Xen based (Amazon), Vmware based 
(vCloud/vSphere) and Hyper-V (Azure). IN our area with Vmware all service 
providers have to adhere to the same stack build in order to be accredited by 
vmware to deliver the services and to ensure that the VMs can move from on 
premise to the vCloud seemlessly. As this becomes more standardised it is 
going to be a lot easier for providers to adhere to simplified "qualification" 
processes for their platforms. For example if you developed a set of 
documents that qualified our platforms they could equally be used by all other 
vmware vCloud providers as they use the same stack. There's a nice 
opportunity out there for someone to do this! 
 
 
 
54 
 
   
Appendix 2  
 
This GMPIA document template represents a way of listing features of a systems´ potential GMP impact. 
 
Finance 
 
Function Description Documentation Regulation reference  
GMP impact 
(Yes/No) Notes 
      
      
      
 
Procurement 
 
Function Description Documentation 
 
Regulation 
reference  
GMP impact 
(Yes/No) Notes 
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Function Description Documentation 
 
Regulation 
reference  
GMP impact 
(Yes/No) Notes 
      
 
Quality Control 
 
Function Description Documentation 
 
Regulation 
reference  
GMP impact 
(Yes/No) Notes 
      
      
      
   
 
 
 
 
Stock Control 
Function Description Documentation 
 
Regulation 
reference  
GMP impact 
(Yes/No) Notes 
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Function Description Documentation 
 
Regulation 
reference  
GMP impact 
(Yes/No) Notes 
      
      
      
 
Other Functions 
Function Description Documentation 
 
Regulation 
reference  
GMP impact 
(yes/No) Notes 
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Appendix 3  
 
This FMEA document template represents a way of documenting mitigation of GMP significant features. 
 
 
 
 
 
 
Item 
Se
ve
rit
y 
O
cc
ur
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nc
e 
D
et
ec
tio
n 
R
PN
 
Preventative Corrective Actions 
Se
ve
rit
y 
O
cc
ur
re
nc
e 
D
et
ec
tio
n 
FI
N
A
L 
R
PN
 
Notes 
                      
1                     
2                     
3                     
 
 
 
 
 
Item Step 
Acceptance criteria / 
range of parameter 
values Failure Cause Effect 
Controls and Detection 
mechanism 
              
1             
2             
3             
58 
 
   
REFERENCES 
 
Assuring Life sciences compliance in the private cloud. 2011. Accessed on  
22.9.2013. http://www.emc.com/collateral/software/service-overview/h7217-
compliant-life-science-svo.pdf   
 
Bittman, T. 2012. Top Five Private Cloud Computing Trends, 2012. 22.3.2012. 
Accessed on 
22.9.2013. http://blogs.gartner.com/thomas_bittman/2012/03/22/top-five-
private-cloud-computing-trends-2012/ 
 
Carstensen J., Golden, B., Morgenthal, JP. 2012. Cloud Computing, 
Assessing the Risks. United Kingdom: IT Governance Publishing. 
 
Cloud Adoption Study: Cloud computing is gaining momentum. 2011. CIOnet 
and Deloitte. Accessed on 12.11.2013. 
http://webserver2.deloitte.com.co/Consultoria/Cloud Adoption Survey.pdf 
 
Cloud computing. 22.9.2013. An article on Wikipedia. Accessed on 22.9.2013. 
http://en.wikipedia.org/wiki/Cloud_computing  
 
Cloud computing security. 26.8.2013. Accessed on 22.9.2013. 
http://en.wikipedia.org/wiki/Cloud_computing_security  
 
Commission Decision 2000/520/EY 32000D0520. 2000. European 
Commission. 25.8.2000. Accessed on 22.9.2013. http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32000D0520:EN:HTML 
 
Consensus Assessments Initiative Questionnaire. 9.1.2011. Accessed on 
22.9.2013. https://cloudsecurityalliance.org/research/cai/ 
 
Cox, P. n.d. Securing data in the cloud. Accessed on 22.9.2013. 
http://www.emacromall.com/techpapers/Is%20Your%20Data%20Safe%20in%
20the%20Cloud.pdf 
 
Directive 95/46/EC. 1995. European Commission. Accessed on 
59 
 
   
22.9.2013. http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31995L0046:en:HTML 
 
Essers, L. 2013. European companies should stop sending data to the US, 
German privacy officials say. 25.7.2013. Accessed on 22.9.2013. 
http://www.pcworld.idg.com.au/article/521980/european_companies_should_s
top_sending_data_us_german_privacy_officials_say/ 
 
EudraLex, The Rules Governing Medicinal Products in the European Union, 
Volume 4 Good Manufacturing Practice Medicinal Products for Human and 
Veterinary Use, Annex 11: Computerised Systems. 2011. European 
Commission. 
 
Failure mode and effects analysis. 19.9.2013. An article on Wikipedia. 
Accessed on 
22.9.2013. http://en.wikipedia.org/wiki/Failure_mode_and_effects_analysis  
 
Francis, S. 2013. Cloud Storage Security Controls. 25.3.2013. Accessed on 
22.9.2013. http://www.cloudtweaks.com/2013/03/cloud-storage-security-
controls/ 
 
Gartner outlines cloud computing strategy shapers. 2.4.2012. Accessed on 
22.9.2013. 
http://www.cloudcow.com/content/gartner-outlines-cloud-computing-strategy-
shapers 
 
General Data Protection Regulation Proposal. 2012. European Commission. 
25.1.2012 Accessed on 22.9.2013. http://ec.europa.eu/justice/data-
protection/document/review2012/com_2012_11_en.pdf 
 
Gorban, A. 2013. Phased Approach to Compliant Cloud Computing. 5.6.2013. 
Accessed on 22.9.2013. http://www.pharmacompliancemonitor.com/phased-
approach-to-compliant-cloud-computing/4987/ 
 
HIPAA Technical Safeguards. n.d. Accessed on 22.9.2013. 
60 
 
   
http://www.hipaasurvivalguide.com/hipaa-regulations/164-312.php 
 
International Register of ISMS Certificates. 2012. ISMS International User 
Group. Accessed on 22.9.2013. http://www.iso27001certificates.com/  
 
Is Symantec Online Storage HIPAA Compliant? Forum post. 12.11.2008. 
Accessed on 22.9.2013. http://www.symantec.com/connect/forums/symantec-
online-storage-hipaa-compliant 
 
ISO27001 Security. 2013. ISO/IEC 27002. Accessed on 22.9.2013. 
http://www.iso27001security.com/html/27002.html 
 
IT risk management. 27.8.2013. An article on Wikipedia. Accessed on 
22.9.2013. 
http://en.wikipedia.org/wiki/IT_risk_management  
 
Karamnova, L. 13.11.2012. Software-as-a-Service Validation. PDF-document 
from IVT conference held on 13.11.2012. 
 
Lassila, A. 2012. EU:n työryhmä: Pilvipalveluiden tietosuojariskit selvitettävä 
huolella. Helsingin Sanomat 28.8.2012. 
 
Ludwig, S. 2011. Cloud 101: What the heck do IaaS, PaaS and SaaS 
companies do? 14.11.2011. Accessed on 22.9.2013. 
http://venturebeat.com/2011/11/14/cloud-iaas-paas-saas/ 
 
Martin, K., Perez, A. 2008. GAMP 5 Quality Risk Management Approach. 
Pharmaceutical Engineering May/June 2008, Vol. 28 No. 3. 
 
Mell, B. 2011. The NIST Definition of Cloud Computing (Draft): Special 
Publication 800-145. Recommendations of the National Institute of Standards 
and Technology.  
 
Mitchell, C. Standardizing. n.d. Privacy and security for the cloud. Accessed 
on 22.9.2013. http://www.chrismitchell.net/Talks/111101.pdf 
61 
 
   
  
New draft European data protection regime. 2012. M Patent Group. 2.2.2012. 
Accessed on 
22.9.2013. http://www.mlawgroup.de/news/publications/detail.php?we_objectI
D=227 
 
NextDocs Compliance Cloud White Paper. 2012. Accessed on 22.9.2013. 
http://www.nextdocs.com/en-us/White%20Papers/Compliance%20Cloud.pdf 
 
Rajinderkaur. 2008. Qualification Vs Validation. Forum post. 24.7.2008.  
http://www.askaboutvalidation.com/forum/showthread.php?979-Qualification-
Vs-Validation 
 
Security Guidance for Critical Areas of Focus in Cloud Computing. 
14.11.2011. Accessed on 
22.9.2013. https://cloudsecurityalliance.org/research/security-guidance/ 
 
Sourya, B. 2011. A History of Cloud Computing. 9.2.2011. Accessed on 
22.9.2013. http://www.cloudtweaks.com/2011/02/a-history-of-cloud-
computing/ 
 
Stokes, D. 2012. Selecting, Qualifying and Validating Cloud Applications. 
PDF-document from IVT conference held on 13.11.2012. 
 
Top 10 cloud computing providers of 2012. 24.4.2012. Accessed 22.9.2013. 
http://searchcloudcomputing.techtarget.com/photostory/2240149038/Top-10-
cloud-providers-of-2012/1/Introduction 
 
Turunen, I. 2011. Deploying FreeNEST Project Platform to an OpenStack 
based cloud platform: A pragmatic study into an emerging technology. B.Sc. 
thesis work. Jyväskylä University of Applied Sciences, Degree Programme in 
Software Engineering Technology, ICT. Accessed on 1.9.2012. 
 
 
62 
 
   
U.S.-EU Safe Harbor homepage. n.d. Accessed 22.9.2013. 
http://export.gov/safeharbor/eu/index.asp 
 
Wang, C. 2009. Cloud Security Front And Center. 18.11.2009. Accessed on 
22.9.2013. http://blogs.forrester.com/security_and_risk/2009/11/cloud-
security-front-and-center.html 
 
